




Healthcare News Roundup: Biopharmaceuticals
HSMN NewsFeed - 22 Mar 2023
Flare Therapeutics Announces Oversubscribed $123 Million Series B Financing
Flare Therapeutics Announces Oversubscribed $123 Million Series B Financing
HSMN NewsFeed - 7 Mar 2023
Capsida Biotherapeutics Appoints Susan Catalano, Ph.D. as Chief Scientific Officer
Capsida Biotherapeutics Appoints Susan Catalano, Ph.D. as Chief Scientific Officer
HSMN NewsFeed - 28 Feb 2023
Verismo Therapeutics Announces $7 Million Pre-Series A with BRV Capital Management as Lead Investor
Verismo Therapeutics Announces $7 Million Pre-Series A with BRV Capital Management as Lead Investor
HSMN NewsFeed - 27 Feb 2023
Viatris Announces Appointment of Scott A. Smith as CEO Effective April 1, 2023
Viatris Announces Appointment of Scott A. Smith as CEO Effective April 1, 2023